New Drug Nearly Doubles Survival for Aggressive Cancer

Women with triple-negative breast cancer, one of the deadliest forms, now have a treatment that nearly doubles how long they live without their disease worsening.

A global trial shows the targeted therapy works far better than standard chemotherapy.